Innovation at GlaxoSmithKline: is it the safest way? How to ensure creativity enhances your business without threatening the bottom line

Strategic Direction

ISSN: 0258-0543

Publication date: 1 July 2004

Abstract

Creativity, so business theorists say, is a firm’s most valuable asset. We’ve all heard the mantras: “ideas are the future!” “innovate or die!” Getting the message is easy enough but for a lot of firms developing and harnessing creative ideas is easier said than done. Creativity is a particularly difficult notion for managers to have to deal with and, more importantly, account for. How do we decide we can afford to change the way we do things and invest in developing new ideas without the proof they are going to pay off?

Keywords

Citation

(2004), "Innovation at GlaxoSmithKline: is it the safest way? How to ensure creativity enhances your business without threatening the bottom line", Strategic Direction, Vol. 20 No. 7, pp. 16-18. https://doi.org/10.1108/02580540410540787

Publisher

:

Emerald Group Publishing Limited

Copyright © 2004, Emerald Group Publishing Limited

To read the full version of this content please select one of the options below

You may be able to access this content by logging in via Shibboleth, Open Athens or with your Emerald account.
To rent this content from Deepdyve, please click the button.
If you think you should have access to this content, click the button to contact our support team.